No significant impact of patient age and prior treatment profile with docetaxel on the efficacy of cabazitaxel in patient with castration-resistant prostate cancer (Englisch)
Freier Zugriff
- Neue Suche nach: Kosaka, Takeo
- Weitere Informationen zu Kosaka, Takeo:
- https://orcid.org/0000-0002-4371-4594
- Neue Suche nach: Hongo, Hiroshi
- Neue Suche nach: Watanabe, Keitaro
- Neue Suche nach: Mizuno, Ryuichi
- Neue Suche nach: Kikuchi, Eiji
- Neue Suche nach: Oya, Mototsugu
- Neue Suche nach: Kosaka, Takeo
- Weitere Informationen zu Kosaka, Takeo:
- https://orcid.org/0000-0002-4371-4594
- Neue Suche nach: Hongo, Hiroshi
- Neue Suche nach: Watanabe, Keitaro
- Neue Suche nach: Mizuno, Ryuichi
- Neue Suche nach: Kikuchi, Eiji
- Neue Suche nach: Oya, Mototsugu
In:
Cancer Chemotherapy and Pharmacology
;
82
, 6
; 1061-1066
;
2018
-
ISSN:
- Aufsatz (Zeitschrift) / Elektronische Ressource
-
Titel:No significant impact of patient age and prior treatment profile with docetaxel on the efficacy of cabazitaxel in patient with castration-resistant prostate cancer
-
Beteiligte:Kosaka, Takeo ( Autor:in ) / Hongo, Hiroshi ( Autor:in ) / Watanabe, Keitaro ( Autor:in ) / Mizuno, Ryuichi ( Autor:in ) / Kikuchi, Eiji ( Autor:in ) / Oya, Mototsugu ( Autor:in )
-
Erschienen in:Cancer Chemotherapy and Pharmacology ; 82, 6 ; 1061-1066
-
Verlag:
- Neue Suche nach: Springer Berlin Heidelberg
- Neue Suche nach: Springer
-
Erscheinungsort:Berlin
-
Erscheinungsdatum:2018
-
ISSN:
-
ZDBID:
-
DOI:
-
Medientyp:Aufsatz (Zeitschrift)
-
Format:Elektronische Ressource
-
Sprache:Englisch
- Neue Suche nach: 44.40 / 44.38
- Weitere Informationen zu Basisklassifikation
-
Schlagwörter:
-
Klassifikation:
-
Datenquelle:
Inhaltsverzeichnis – Band 82, Ausgabe 6
Zeige alle Jahrgänge und Ausgaben
Die Inhaltsverzeichnisse werden automatisch erzeugt und basieren auf den im Index des TIB-Portals verfügbaren Einzelnachweisen der enthaltenen Beiträge. Die Anzeige der Inhaltsverzeichnisse kann daher unvollständig oder lückenhaft sein.
- 913
-
Autophagy modulation: a prudent approach in cancer treatment?Bishop, Eleanor / Bradshaw, Tracey D. et al. | 2018
- 923
-
Autophagy therapeutics: preclinical basis and initial clinical studiesZhan, Lei / Li, Jun / Wei, Bing et al. | 2018
- 935
-
Outcomes after neoadjuvant treatment with gemcitabine and erlotinib followed by gemcitabine–erlotinib and radiotherapy for resectable pancreatic cancer (GEMCAD 10-03 trial)Maurel, Joan / Sánchez-Cabús, Santiago / Laquente, Berta / Gaba, Lydia / Visa, Laura / Fabregat, Joan / Povés, Ignacio / Roselló, Susana / Díaz-Beveridge, Roberto / Martín-Richard, Marta et al. | 2018
- 945
-
Single agent efficacy of the HDAC inhibitor DATS in preclinical models of glioblastomaDas, Arabinda / Henderson, Fraser / Lowe, Stephen / Wallace, Gerald C. / Vandergrift, William A. / Lindhorst, Scott M. / Varma, Abhay K. / Infinger, Libby K. / Giglio, Pierre / Banik, Narendra L. et al. | 2018
- 953
-
The maximum chemiluminescence intensity predicts severe neutropenia in gemcitabine-treated patients with pancreatic or biliary tract cancerGoto, Koki / Matsuyama, Ryusei / Suwa, Yusuke / Arisaka, Sayaka / Kadokura, Toshiaki / Sato, Mari / Mori, Ryutaro / Kumamoto, Takafumi / Taguri, Masataka / Endo, Itaru et al. | 2018
- 961
-
Safety of trifluridine/tipiracil in an open-label expanded-access program in elderly and younger patients with metastatic colorectal cancerMayer, Robert J. / Hochster, Howard S. / Cohen, Steven J. / Winkler, Robert / Makris, Lukas / Grothey, Axel et al. | 2018
- 971
-
Exposure–response analysis and simulation of lenvatinib safety and efficacy in patients with radioiodine-refractory differentiated thyroid cancerHayato, Seiichi / Shumaker, Robert / Ferry, Jim / Binder, Terri / Dutcus, Corina E. / Hussein, Ziad et al. | 2018
- 979
-
Phase I trial of afatinib and 3-weekly trastuzumab with optimal anti-diarrheal management in patients with HER2-positive metastatic cancerMartin, Nicolas / Isambert, Nicolas / Gomez-Roca, Carlos / Goeldner, Rainer-Georg / Zanetta, Sylvie / Sadrolhefazi, Behbood / de Mont-Serrat, Hélène / Campone, Mario / Delord, Jean-Pierre et al. | 2018
- 987
-
Relationship between folate concentration and expression of folate-associated genes in tissue and plasma after intraoperative administration of leucovorin in patients with colorectal cancerTaflin, Helena / Odin, Elisabeth / Derwinger, Kristoffer / Carlsson, Göran / Gustavsson, Bengt / Wettergren, Yvonne et al. | 2018
- 999
-
Lactobacillus supplementation prevents cisplatin-induced cardiotoxicity possibly by inflammation inhibitionZhao, Lianbi / Xing, Changyang / Sun, Wenqi / Hou, Guangli / Yang, Guodong / Yuan, Lijun et al. | 2018
- 1009
-
Oleandrin synergizes with cisplatin in human osteosarcoma cells by enhancing cell apoptosis through activation of the p38 MAPK signaling pathwayYong, Lei / Ma, Yunlong / Zhu, Bin / Liu, Xiao / Wang, Peng / Liang, Chen / He, Guanping / Zhao, Zhigang / Liu, Zhongjun / Liu, Xiaoguang et al. | 2018
- 1021
-
A phase II study of NK012, a polymeric micelle formulation of SN-38, in unresectable, metastatic or recurrent colorectal cancer patientsHamaguchi, Tetsuya / Tsuji, Akihito / Yamaguchi, Kensei / Takeda, Koji / Uetake, Hiroyuki / Esaki, Taito / Amagai, Kenji / Sakai, Daisuke / Baba, Hideo / Kimura, Masami et al. | 2018
- 1031
-
A phase II trial of EGFR-TKI readministration with afatinib in advanced non-small-cell lung cancer harboring a sensitive non-T790M EGFR mutation: Okayama Lung Cancer Study Group trial 1403Oda, Naohiro / Hotta, Kastuyuki / Ninomiya, Kiichiro / Minami, Daisuke / Ichihara, Eiki / Murakami, Toshi / Yokoyama, Toshihide / Ichikawa, Hirohisa / Chikamori, Kenichi / Takigawa, Nagio et al. | 2018
- 1039
-
Oncogenic roles of serine–threonine kinase receptor-associated protein (STRAP) in osteosarcomaPruksakorn, Dumnoensun / Klangjorhor, Jeerawan / Lirdprapamongkol, Kriengsak / Teeyakasem, Pimpisa / Sungngam, Patsadakorn / Chaiyawat, Parunya / Phanphaisarn, Areerak / Settakorn, Jongkolnee / Srisomsap, Chantragan et al. | 2018
- 1049
-
FOXC2 promotes epithelial–mesenchymal transition and cisplatin resistance of non-small cell lung cancer cellsHe, Yuwen / Xie, Hui / Yu, Pengjiu / Jiang, Shunjun / Wei, Li et al. | 2018
- 1061
-
No significant impact of patient age and prior treatment profile with docetaxel on the efficacy of cabazitaxel in patient with castration-resistant prostate cancerKosaka, Takeo / Hongo, Hiroshi / Watanabe, Keitaro / Mizuno, Ryuichi / Kikuchi, Eiji / Oya, Mototsugu et al. | 2018
- 1067
-
Pharmacokinetic evaluation of the PNC disassembler metarrestin in wild-type and Pdx1-Cre;LSL-$ Kras^{G12D/+} $;$ Tp53^{R172H/+} $ (KPC) mice, a genetically engineered model of pancreatic cancerVilimas, Tomas / Wang, Amy Q. / Patnaik, Samarjit / Hughes, Emma A. / Singleton, Marc D. / Knotts, Zachary / Li, Dandan / Frankowski, Kevin / Schlomer, Jerome J. / Guerin, Theresa M. et al. | 2018
- 1081
-
Enhancing 5-fluorouracil efficacy through suppression of PKM2 in colorectal cancer cellsCao, Yong / Lin, Yan / Wang, Dongxu / Pan, Di / Zhang, Ying / Jin, Yu / Zheng, Changqing et al. | 2018
- 1087
-
Comment on: Yohshino et al.: combination chemotherapy with irinotecan and gemcitabine for taxane/platinum-resistant/refractory ovarian and primary peritoneal cancer: a multicenter phase I/II trial (GOGO-Ov 6). Cancer Chemother Pharmacol (2017) 80:1239–1247Eichbaum, Michael / Eichbaum, Christine et al. | 2018
- 1089
-
Acknowledgement of reviewers 2017| 2018